Birdwatch Archive

Birdwatch Note Rating

2024-05-25 22:35:06 UTC - HELPFUL

Rated by Participant: F2C60307B1C4BFD340D8559AD83D6EE8C1E2D1C30AC6553CB7104A09948C554A
Participant Details

Original Note:

O estudo citado compara desfechos em pacientes diabéticos com doença renal crônica que usaram semaglutida vs placebo. A dose usada foi a indicada na bula para diabetes, não para obesidade, com acompanhamento de 3 anos. Os benefícios foram comprovados NESSA POPULAÇÃO SOMENTE. www.washingtonpost.com/health/2024/05/24/ozempic-kidney-disease-study

All Note Details

Original Tweet

All Information

  • noteId - 1794476235038355877
  • participantId -
  • raterParticipantId - F2C60307B1C4BFD340D8559AD83D6EE8C1E2D1C30AC6553CB7104A09948C554A
  • createdAtMillis - 1716676506042
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1794476235038355877F2C60307B1C4BFD340D8559AD83D6EE8C1E2D1C30AC6553CB7104A09948C554A